Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

EpiThany

EpiThany
2014 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
1 INVESTORS
Description

Developer of innovative therapies created to improve the lives of cancer patients. The company develops anti-cancer immunotherapy for robust tumor-targeted T-cell immunity, enabling the targeting of a multitude of tumor antigens across a spectrum of cancers, driving Th1-selective (tumor-eradicating) immune responses.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Primary Office
  • 3240 Fuhrman Avenue East
  • Suite 106
  • Seattle, WA 98102
  • United States

+1 (206) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore EpiThany’s full profile, request a free trial.

EpiThany Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Clinical Trials - Phase 1
To view this company’s complete deal history including valuation and funding, request access »

EpiThany Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Immunomic Therapeutics Venture Capital-Backed Rockville, MD 00 000.00 0000000000 0 000.00
000000000 00000000 Formerly VC-backed Emeryville, CA 000 00000 00000000 00000
0000 000000000000 Formerly VC-backed Cambridge, MA 000 00000 00000000 00000
000000 00000000000 Corporation Plymouth Meeting, PA 000 000.00 0000000000 000.00
To view this company’s complete list of competitors, request access »

EpiThany Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
WRF Capital Venture Capital Minority 000 0000 000000 0

EpiThany Executive Team (3)

Name Title Board
Seat
Contact
Info
William Watt Ph.D Co-Founder, President, Board Member & Chief Executive Officer
David Poston Chief Operating Officer
Mary Disis MD Scientific Co-Founder

EpiThany Board Members (3)

Name Representing Role Since Contact
Info
Martin Simonetti Sr. Self Board Member 000 0000
Michael Gallatin Ph.D Self Board Member 000 0000
William Watt Ph.D EpiThany Co-Founder, President, Board Member & Chief Executive Officer 000 0000